You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • OP0095 Randomized, Placebo-Controlled Trial To Evaluate Clinical Efficacy and Structure Modifying Properties of Subcutaneous Etanercept (ETN) in Patients with Erosive Inflammatory Hand Osteoarthritis (OA)

Article metrics

Article menu
Download PDFPDF
Oral Presentations
New horizons in osteoarthiritis
OP0095 Randomized, Placebo-Controlled Trial To Evaluate Clinical Efficacy and Structure Modifying Properties of Subcutaneous Etanercept (ETN) in Patients with Erosive Inflammatory Hand Osteoarthritis (OA)

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016300
Aug 20161402
Sep 2016702
Oct 20161601
Nov 20161203
Dec 20162101
Jan 20171401
Feb 20172801
Mar 20172602
Apr 20171201
May 20171602
Jun 2017700
Jul 20171403
Aug 20172202
Sep 20173201
Oct 20175005
Nov 20172400
Dec 20171203
Jan 20181601
Feb 20181000
Mar 20181600
Apr 20182000
May 20182601
Jun 20182603
Jul 20183603
Aug 20181400
Sep 20181000
Oct 20182401
Nov 20181401
Dec 20181400
Jan 20191300
Feb 2019600
Mar 20191200
Apr 20191700
May 20191601
Jun 2019200
Jul 20191000
Aug 2019400
Sep 2019600
Oct 20191700
Nov 20191802
Dec 2019600
Jan 2020800
Feb 20201902
Mar 2020601
Apr 2020702
May 20204000
Jun 20201400
Jul 20201600
Aug 20203301
Sep 20202700
Oct 20202801
Nov 20202401
Dec 20201501
Jan 20212001
Feb 20211100
Mar 20211400
Apr 2021600
May 20215400
Jul 2021100
Aug 2021301
Sep 2021102
Oct 20212101
Nov 20211000
Dec 20212501
Jan 20223000
Feb 20223700
Mar 20221600
Apr 20221001
May 20222401
Jun 20222400
Jul 20221800
Aug 20222000
Sep 20222200
Oct 20221800
Nov 20221200
Dec 20222601
Jan 20232300
Feb 20231600
Mar 20231300
Apr 20231001
May 20231000
Jun 2023800
Jul 2023900
Aug 2023200
Sep 20231600
Oct 2023200
Nov 2023200
Dec 20231702
Jan 20242204
Feb 20241000
Mar 2024800
Total1511068